Latest News & Features
Refine Search
Big Pharma
 Panellists at the Life Sciences Patent Network Europe  conference in London today discussed the challenges around a potential unitary supplementary protection certificate.   6 December 2017 
Big Pharma
 A lawyer speaking at the Life Sciences Patent Network Europe conference has said the US Patent Trial and Appeal Board (PTAB) has come under fire for not being politically independent.   6 December 2017 
Europe
 UK-based genomics company Horizon Discovery has expanded its licence coverage for use of the CRISPR gene-editing technology.   5 December 2017 
Americas
 The US Supreme Court has refused to rule on a patent dispute between agricultural companies Dow AgroSciences and Bayer CropScience.   5 December 2017 
Americas
 Technology company Philips and Massachusetts-based Zoll Medical appear to be nearing a settlement in their patent dispute over defibrillators.   4 December 2017 
Americas
 The Computer & Communications Industry Association (CCIA) and the Association for Accessible Medicines (AAM) have urged the Patent Trial and Appeal Board (PTAB) to dismiss a Native American tribe’s attempt to shut down a series of inter partes reviews (IPRs).   4 December 2017 
Americas
 Medical technology company Stryker has been sued for trademark infringement relating to educational services it offers to surgeons, doctors and other medical professionals.   1 December 2017 
Big Pharma
 The World Health Organization (WHO) has released a study on the public health impact of counterfeit drugs, showing that tens of thousands of children die as a result of the problem every year.   30 November 2017 
Europe
 The Broad Institute of MIT and Harvard may lose a substantial number of European patent claims covering CRISPR/Cas9, but it has at least one trump card to play before we get to that stage, one European patent attorney has told LSIPR.   30 November 2017 
Americas
 A group of Miami police officers has filed a competition lawsuit on behalf of “potentially millions” of consumers over Allergan’s $13.75 million patent deal with the Saint Regis Mohawk Tribe.   30 November 2017 

